Proteomics and its Application to Translational and Precision Medicine (D3)
Proteomics and its Application to Translational and Precision Medicine (D3) is organized by Keystone Symposia on Molecular and Cellular Biology and will be held from Apr 07 - 11, 2019 at Clarion Hotel Sign, Stockholm, Sweden.
Course Description :
Proteomics methods have advanced tremendously in just the last few years. Apart from increasingly powerful mass-spectrometric methods, global antibody based methods, chemical biology approaches and genetics/genomics approaches and their combinations are now offering a rich toolbox to study the proteome in many different dimensions. Given this background and the recent completion of in depth proteomes, clearly the time is right to apply proteomics in a more translational context to patient derived primary cells, organoids, xenograft models and indeed to the clinic. Such activities are well underway and we will focus on several distinct areas in this conference. MS based proteomics, in particular interaction proteomics in combination with chemical and structural proteomics, is making crucial contributions to drug development and deeper molecular understanding of disease mechanisms. The analysis of post-translational modifications has become orders of magnitude more comprehensive, quantitative and accessible, now enabling in-vivo and time-resolved studied of a large range of signaling processes. In combination with genome engineering, this opens up entirely new perspectives in precision investigation of deregulated signaling processes in models of oncology, immunology or metabolic diseases. Finally, proteomic profiling of body fluids has matured to a degree that it enables informative ‘phenotyping’ of humans in health and disease, supporting ‘wellness’ and patient stratification/biomarker studies.
Additional details will be posted as soon as they are available.
|Contact No.||:||+1 800-253-0685,
|Registration Type||Due Date||Price|
|Registation Early Fee||06 Feb,2019||USD 945.00|
|Student Early Fee||06 Feb,2019||USD 720.00|